Associate Director, Analytical Development -Protein Based Assays jobs in United States
cer-icon
Apply on Employer Site
company-logo

Kriya Therapeutics, Inc. · 2 months ago

Associate Director, Analytical Development -Protein Based Assays

Kriya Therapeutics, Inc. is a biopharmaceutical company focused on developing gene therapies for diseases with high unmet needs. The Associate Director, Analytical Development will lead the development and optimization of analytical methods for AAV gene therapy, while managing a team to support multiple late-phase programs.

BiotechnologyHealth CareLife ScienceNeuroscience
check
Growth Opportunities
check
H1B Sponsor Likelynote

Responsibilities

Lead a team tasked with developing analytical strategy for protein- and HPLC-based AAV gene therapy vector release and characterization
Contribute to science-driven, phase appropriate, and risk-based analytical development and specification setting to support all programs in the company
Serve as a subject matter expert and author and/or review relevant sections of documentation in support of INDs and other regulatory submissions
Seek out and analyze data from a variety of sources to support decisions
Make sound decisions regarding complex technical issues and communicate decisions effectively with internal stakeholders, elevating complex issues as appropriate
Lead and supervise the team technically to stay up-to-date and ensure high quality analytical capability
Coordinate sample plans cross-functionally to support phase appropriate development

Qualification

AAV gene therapy experienceAnalytical method developmentChromatographyELISACapillary ElectrophoresisStatistical methodsTeam managementCommunication skillsSelf-motivatedCollaboration

Required

PhD degree in Science, Biotechnology, Engineering or other related field and 5 years of industry experience, Master's degree and 8 years of experience, or Bachelor's degree and 10 years of experience
Demonstrate in-depth experience of the development, qualification, and implementation of analytical methods for the characterization and release testing of AAV vectors or biologic products in an industry setting
Experience with analytical techniques including Chromatography, ELISA, Capillary Electrophoresis strongly preferred
Sound understanding and demonstrated application of statistical methods/tools
Strong verbal, written, and interpersonal communication skills
Self-motivated, organized, capable of working independently and in a collaborative environment
Exercise of discretion and independent judgment
Ability and desire to work in a fast paced, startup environment
An ability to build effective relationships and work cross-functionally to deliver results and meet business objectives

Preferred

PhD preferred
Relevant AAV gene therapy experience in leading analytical development is preferred
Previous experience managing, coaching, and providing direction to technical staff in an industry setting is preferred
Experience with characterization and release testing of viral vector-based systems, plasmid DNA, or RNA products a plus
Late-stage method development and regulatory experience a plus

Benefits

Medical, Dental and Vision
401(k) with Company Match
Short and Long-term Disability Benefits
Company Paid Holidays
Flexible Time Off
Cyber Safety protection
EAP
Life Insurance
Equity
And more!

Company

Kriya Therapeutics, Inc.

twittertwittertwitter
company-logo
Our mission is to revolutionize medicine, with the ultimate goal of eliminating human suffering and enabling people to live without the burden of disease.

H1B Sponsorship

Kriya Therapeutics, Inc. has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2023 (1)
2022 (3)

Funding

Current Stage
Late Stage
Total Funding
$921.32M
Key Investors
Patient Square CapitalQVT FinancialTranshuman Capital
2025-08-15Series D· $320.82M
2023-07-26Series C· $150M
2022-05-16Series C· $270M

Leadership Team

leader-logo
Shankar Ramaswamy
Co-Founder and Chief Executive Officer
linkedin
leader-logo
Sachiyo Minegishi
Chief Financial Officer
linkedin
Company data provided by crunchbase